Renewal of inclusion on the list of medicines refundable by National Health Insurance.
-
Clinical Benefit
Substantial
The actual benefit provided by this proprietary medicinal product is substantial in the treatment and prevention of spinal osteoporosis, solely in patients at low risk of femoral neck fracture, aged less than 70 years and with no risk factors for venous thromboembolic events (lack of personal or family history of venous thromboembolic events).
Listen
